Melatonin induces apoptosis of colorectal cancer cells through HDAC4 nuclear import mediated by CaMKII inactivation

Melatonin induces apoptosis in many different cancer cell lines, including colorectal cancer. However, the precise mechanisms involved remain largely unresolved. In this study, we provide evidence to reveal a new mechanism by which melatonin induces apoptosis of colorectal cancer LoVo cells. Melatonin at pharmacological concentrations significantly suppressed cell proliferation and induced apoptosis in a dose‐dependent manner. The observed apoptosis was accompanied by the melatonin‐induced dephosphorylation and nuclear import of histone deacetylase 4 (HDAC4). Pretreatment with a HDAC4‐specific siRNA effectively attenuated the melatonin‐induced apoptosis, indicating that nuclear localization of HDAC4 is required for melatonin‐induced apoptosis. Moreover, constitutively active Ca2+/calmodulin‐dependent protein kinase II alpha (CaMKIIα) abrogated the melatonin‐induced HDAC4 nuclear import and apoptosis of LoVo cells. Furthermore, melatonin decreased H3 acetylation on bcl‐2 promoter, leading to a reduction of bcl‐2 expression, whereas constitutively active CaMKIIα(T286D) or HDAC4‐specific siRNA abrogated the effect of melatonin. In conclusion, the present study provides evidence that melatonin‐induced apoptosis in colorectal cancer LoVo cells largely depends on the nuclear import of HDAC4 and subsequent H3 deacetylation via the inactivation of CaMKIIα.

[1]  N. Weerapreeyakul,et al.  Melatonin potentiates cisplatin‐induced apoptosis and cell cycle arrest in human lung adenocarcinoma cells , 2015, Cell proliferation.

[2]  K. Thumanu,et al.  Melatonin induces apoptosis through biomolecular changes, in SK‐LU‐1 human lung adenocarcinoma cells , 2014, Cell proliferation.

[3]  Yiqiang Zhang,et al.  Melatonin: a well‐documented antioxidant with conditional pro‐oxidant actions , 2014, Journal of pineal research.

[4]  M. Bizzarri,et al.  Melatonin down‐regulates MDM2 gene expression and enhances p53 acetylation in MCF‐7 cells , 2014, Journal of pineal research.

[5]  E. A. Queiroz,et al.  Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells , 2014, PloS one.

[6]  J. Salmerón,et al.  Melatonin reduces endothelin‐1 expression and secretion in colon cancer cells through the inactivation of FoxO‐1 and NF‐κβ , 2014, Journal of pineal research.

[7]  Yonggeun Hong,et al.  Melatonin treatment induces interplay of apoptosis, autophagy, and senescence in human colorectal cancer cells , 2014, Journal of pineal research.

[8]  R. Reiter,et al.  Extrapineal melatonin: sources, regulation, and potential functions , 2014, Cellular and Molecular Life Sciences.

[9]  M. Bizzarri,et al.  Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review , 2013, Expert opinion on therapeutic targets.

[10]  R. Reiter,et al.  Melatonin induces apoptosis through a caspase‐dependent but reactive oxygen species‐independent mechanism in human leukemia Molt‐3 cells , 2013, Journal of pineal research.

[11]  Wenlin Huang,et al.  Melatonin potentiates the antiproliferative and pro‐apoptotic effects of ursolic acid in colon cancer cells by modulating multiple signaling pathways , 2013, Journal of pineal research.

[12]  R. Reiter,et al.  On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK , 2013, Journal of pineal research.

[13]  M. Illario,et al.  N-(Phenoxyalkyl)amides as MT(1) and MT(2) ligands: antioxidant properties and inhibition of Ca(2+)/CaM-dependent kinase II. , 2013, Bioorganic & medicinal chemistry.

[14]  G. Siegal,et al.  Alpha-CaMKII Plays a Critical Role in Determining the Aggressive Behavior of Human Osteosarcoma , 2013, Molecular Cancer Research.

[15]  J. Mayo,et al.  Phenotypic changes caused by melatonin increased sensitivity of prostate cancer cells to cytokine‐induced apoptosis , 2013, Journal of pineal research.

[16]  R. Reiter,et al.  A review of the molecular aspects of melatonin’s anti‐inflammatory actions: recent insights and new perspectives , 2013, Journal of pineal research.

[17]  Josep M. Guerrero,et al.  Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines , 2012, Journal of pineal research.

[18]  Wenlin Huang,et al.  Simultaneous modulation of COX‐2, p300, Akt, and Apaf‐1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells , 2012, Journal of pineal research.

[19]  Wei Wei,et al.  Melatonin sensitizes human hepatoma cells to endoplasmic reticulum stress–induced apoptosis , 2012, Journal of pineal research.

[20]  L. Fuentes-Broto,et al.  Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin , 2012, Journal of pineal research.

[21]  K. Herrup,et al.  Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia-telangiectasia , 2012, Nature Medicine.

[22]  M. Esteller,et al.  Cancer epigenomics: beyond genomics. , 2012, Current opinion in genetics & development.

[23]  S. Myung,et al.  A Novel Pathway Underlying the Inhibitory Effects of Melatonin on Isolated Rat Urinary Bladder Contraction , 2012, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[24]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[25]  G. García‐Santos,et al.  Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway , 2010, Journal of pineal research.

[26]  Alcino J. Silva,et al.  Calmodulin-Kinases: Modulators of Neuronal Development and Plasticity , 2009, Neuron.

[27]  S. Joo,et al.  Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer , 2009, Journal of pineal research.

[28]  R. Reiter,et al.  Melatonin induces mitochondrial‐mediated apoptosis in human myeloid HL‐60 cells , 2009, Journal of pineal research.

[29]  S. Doublier,et al.  Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium‐dependent activation of HIF‐1α and P‐glycoprotein overexpression , 2009, British journal of pharmacology.

[30]  Ju-Young Kim,et al.  Melatonin attenuates lipopolysaccharide‐induced acute lung inflammation in sleep‐deprived mice , 2009, Journal of pineal research.

[31]  M. Pawlikowski,et al.  Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro. , 2009, Neuro endocrinology letters.

[32]  J. McDonald,et al.  Calcium/calmodulin‐dependent kinase II regulates notch‐1 signaling in prostate cancer cells , 2009, Journal of cellular biochemistry.

[33]  J. González‐Gallego,et al.  Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line , 2008, Journal of pineal research.

[34]  H. Ahsan,et al.  Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl‐2 ratio , 2008, The Prostate.

[35]  E. Olson,et al.  Histone Deacetylase 5 Acquires Calcium/Calmodulin-Dependent Kinase II Responsiveness by Oligomerization with Histone Deacetylase 4 , 2008, Molecular and Cellular Biology.

[36]  Ji-Young Kim,et al.  Caspase‐dependent apoptosis induction by targeted expression of DEK in drosophila involves histone acetylation inhibition , 2008, Journal of cellular biochemistry.

[37]  H. Nielsen,et al.  Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer , 2008, Scandinavian journal of gastroenterology.

[38]  A Hicsonmez,et al.  Melatonin prevents inflammation and oxidative stress caused by abdominopelvic and total body irradiation of rat small intestine. , 2007, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[39]  R. Reiter,et al.  Medical implications of melatonin: receptor-mediated and receptor-independent actions. , 2007, Advances in medical sciences.

[40]  E. Feuer,et al.  Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000–2020 , 2006, Cancer Causes & Control.

[41]  F. Herrera,et al.  Melatonin induces apoptosis in human neuroblastoma cancer cells , 2006, Journal of pineal research.

[42]  H. Zhang,et al.  Tumor suppressor pp32 represses cell growth through inhibition of transcription by blocking acetylation and phosphorylation of histone H3 and initiating its proapoptotic activity , 2006, Cell Death and Differentiation.

[43]  R. Mantovani,et al.  DNA Damage Promotes Histone Deacetylase 4 Nuclear Localization and Repression of G2/M Promoters, via p53 C-terminal Lysines* , 2006, Journal of Biological Chemistry.

[44]  S. Caputi,et al.  Melatonin provokes cell death in human B‐lymphoma cells by mitochondrial‐dependent apoptotic pathway activation , 2005, Journal of pineal research.

[45]  T. Yao,et al.  Intracellular Trafficking of Histone Deacetylase 4 Regulates Neuronal Cell Death , 2005, The Journal of Neuroscience.

[46]  H. Duan,et al.  Histone Deacetylase Inhibitors Down-Regulate bcl-2 Expression and Induce Apoptosis in t(14;18) Lymphomas , 2005, Molecular and Cellular Biology.

[47]  G. Benítez-King,et al.  Calmodulin mediates melatonin cytoskeletal effects , 1993, Experientia.

[48]  G. Del Sal,et al.  Caspase-dependent regulation of histone deacetylase 4 nuclear-cytoplasmic shuttling promotes apoptosis. , 2004, Molecular biology of the cell.

[49]  C. Ulrich,et al.  Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients , 2003, Diabetologia.

[50]  A. V. van Kuilenburg,et al.  Histone deacetylases (HDACs): characterization of the classical HDAC family. , 2003, The Biochemical journal.

[51]  K. Fukunaga,et al.  Ca2+/calmodulin‐dependent protein kinase II‐dependent long‐term potentiation in the rat suprachiasmatic nucleus and its inhibition by melatonin , 2002, Journal of neuroscience research.

[52]  T. Soderling,et al.  Cellular Signaling through Multifunctional Ca2+/Calmodulin-dependent Protein Kinase II* , 2001, The Journal of Biological Chemistry.

[53]  A. Medline,et al.  Possible mechanisms relating diet and risk of colon cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[54]  S. Hishinuma,et al.  Ca2+/Calmodulin‐Mediated Regulation of the Desensitizing Process in Gq Protein‐Coupled Histamine H1 Receptor‐Mediated Ca2+ Responses in Human U373 MG Astrocytoma Cells , 2000, Journal of neurochemistry.

[55]  K. Elkon Caspases , 1999, The Journal of Experimental Medicine.

[56]  A. Strasser,et al.  The Bcl-2 protein family. , 1999, Results and problems in cell differentiation.

[57]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[58]  H. Vogel,et al.  Melatonin and serotonin interactions with calmodulin: NMR, spectroscopic and biochemical studies. , 1998, Biochimica et biophysica acta.

[59]  G. Salvesen,et al.  Caspases: Intracellular Signaling by Proteolysis , 1997, Cell.

[60]  G. Benítez-King,et al.  In vitro inhibition of Ca2+/calmodulin-dependent kinase II activity by melatonin. , 1996, Biochimica et biophysica acta.

[61]  G. Benítez-King,et al.  Binding of 3H-melatonin to calmodulin. , 1993, Life sciences.

[62]  G. Benítez-King,et al.  Melatonin modifies calmodulin cell levels in MDCK and N1E-115 cell lines and inhibits phosphodiesterase activity in vitro , 1991, Brain Research.

[63]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.